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Mitochondrial diseaseMitochondria are organelles whose main function is to generate power by oxidative phosphorylation. Some
of the essential genes required for this energy production are encoded by the mitochondrial genome, a small
circular double stranded DNA molecule. Human mtDNA is replicated by a specialized machinery distinct
from the nuclear replisome. Defects in the mitochondrial replication machinery can lead to loss of genetic
information by deletion and/or depletion of the mtDNA, which subsequently may cause disturbed oxidative
phosphorylation and neuromuscular symptoms in patients. We discuss here the different components of the
mitochondrial replication machinery and their role in disease. We also review the mode of mammalian
mtDNA replication.46 31 416108.
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Mitochondria are eukaryotic intracellular organelles that play a
central role in metabolism, being responsible for the conversion of
energy into forms that can be utilized by the cell. The oxidative
phosphorylation (OXPHOS) pathway harvests the energy in nutrients
and transforms it into adenosine triphosphate (ATP). Thirteen genes
that encode for essential subunits of this OXPHOS system are located
in the mitochondrial DNA (mtDNA), a small circular genome that is
separate from nuclear DNA (Fig. 1) [1,2]. Like chromosomal DNA in
bacteria [3], the DNA inside the mitochondria is organized in protein-
DNA structures called nucleoids [4–6]. Transcription factor A (TFAM)
is a major component of the nucleoid and appears to bind and cover
the entire mtDNA molecule [7–9]. Atomic force microscopy studies of
Abf2, the yeast homologue of TFAM, revealed that the protein could
compact the DNA [10,11]. TFAM levels contribute directly to the
regulation of mtDNA copy number, since there is a linear relationship
between TFAM levels and the amount of mtDNA [12,13]. MtDNA
requires TFAM for its maintenance and conversely, TFAM is depleted
in vivo in the absence of mtDNA. The unstable nature of these two key
nucleoid components in vivomay be of importance for cell's ability to
rapidly adjust mtDNA levels in response to altered metabolic needs.
Of the human mitochondrial nucleoid proteins, TFAM is one of the
few factors that has a clear, structural role for nucleoid organization
[5]. A number of other proteins associate with mtDNA during
puriﬁcation and have therefore been assigned as “nucleoid compo-nents.” Some of these will most likely be enzymes, that associate with
the nucleoid during processes such as DNA replication and transcrip-
tion, e.g. DNA polymerase gamma (POLγ), the replicative DNA
helicase TWINKLE, the mitochondrial single-stranded DNA binding
protein (mtSSB), mitochondrial RNA polymerase (POLRMT), and
mitochondrial transcription termination factor mTERF1 (or mTERF)
[8,14,15].
MtDNA-related syndromes are genetically heterogeneous disor-
ders with a relatively broad range of different phenotypes [16]. The
major cause of these diseases is a defective OXPHOS system, which in
turn results in impaired ATP production. This can be a result of mu-
tations in genes involved in complex assembly, mitochondrial protein
synthesis or, more directly, in mtDNA encoded subunits of the
OXPHOS system [16]. Given the limited number of genes that are
encoded by mtDNA, many disorders that result in an OXPHOS defect
are primarily caused by mutations in nuclear genes. One particular
group consists of mutations in the nuclear genes encoding proteins
involved in mtDNA maintenance, which may cause mtDNA altera-
tions, i.e. depletion, deletions or mutations.
Faithful copying of mtDNA is fundamental for proper ATP pro-
duction and maintenance of the mitochondrial membrane potential.
Mitochondria contain unique enzymatic machinery, which is com-
pletely distinct from the DNA replication machinery that maintains
the nuclear genome (Fig. 2). All proteins required for mtDNA
maintenance are encoded in the nucleus, translated in the cytosol
and imported into the mitochondria. Compared to the nuclear
counterparts, the mtDNA replication machinery is extremely simple,
since it is related to the replication apparatus found encoded by
bacteriophages [17]. This makes the mtDNA replication machinery
accessible and attractive for in vitro biochemical analysis. Decades of
Fig. 1. The human mitochondrial genome. The human mitochondrial genome consists
of 16568 base pairs and contains a heavy- and (H-strand) light-strand (L-strand).
Complex I NADH dehydrogenase (ND) genes are shown in green; Complex III
cytochrome b (Cytb) gene is shown in red; Complex IV cytochrome c oxidase (COX)
genes are shown in light blue; Complex V ATP synthese (ATPase) genes are shown in
gray. Transfer RNA genes in black and ribosomal RNA genes (rRNA) in yellow.
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DNA replication machinery and the knowledge generated from this
work may now be used for future studies of mtDNA replication
[18,19]. In addition, genetic analysis of mtDNA replication is difﬁcult,
since no methods are available that allows effective DNA transfection
of mitochondria in intact cells. Therefore, the type of structure-
function studies that has been used to deﬁne DNA elements required
for DNA replication in bacteria and yeast cannot be applied to
mitochondria.
The basal mtDNA replication machinery can be reconstituted in
vitro using only ﬁve highly puriﬁed, recombinant proteins and a DNA
substrate [20,21]. The proteins required are the catalytic subunit of
DNA Polymerase gamma (POLγA), its processivity subunit (POLγB),Fig. 2. ThemtDNA replicationmachinery. The TWINKLE helicase (blue)moves in a 5' to 3'
direction while unwinding dsDNA. The mtSSB protein (dark green) stabilizes the single
stranded conformation and stimulates the DNA synthesis by the POLγ (red (A) and gray
(B)). POLRMT (light green) synthesizes the RNA primer (yellow line) needed for lagging
strand DNA synthesis.the replicative DNA helicase TWINKLE, the mitochondrial single-
stranded DNA-binding protein mtSSB, and the mitochondrial RNA
polymerase (POLRMT) [4,22–25]. Even though many of the key
components present at the mammalian mtDNA replication fork have
been identiﬁed, there is still an ongoing scientiﬁc debate about the
exact mechanisms of mtDNA replication.
2. DNA polymerase gamma
The earliest experiment demonstrating the essential function of
POLγ in mtDNA maintenance was the inactivation of MIP1, the gene
encoding POLγ in budding yeast [26,27]. Although the Mip1 protein
shares about 40% amino acid sequence identity with the human
POLγA, it differs in that it does not require a processivity factor [28].
POLγA defects are associated with a range of disorders such as pro-
gressive external opthalmoplegia (PEO), Alpers syndrome, and male
infertility (for review see [29]). Mutations in POLγB that are unable to
stimulate the processivity of the catalytic subunit are also known to
cause PEO, a disease which is associated with a progressive ac-
cumulation of mtDNA deletion in post-mitotic tissue [30]. How POLγ
performs its tasks in DNA metabolism has been discussed in a couple
of recent reviews [31,32] and here we will highlight more recent
ﬁndings.
Studies of mtDNA replication have been hampered by the lack of
structural information. Lately this changed when a crystal structure of
human POLγA was described at 3.2 Å resolution [33]. The structure
supports earlier ﬁndings that the POLγ holoenzyme is an asymmetric
245 kDa heterotrimer comprising two subunits of the accessory
subunit (POLγB) and one catalytic subunit (POLγA) [34,35]. The
POLG1 gene that codes for POLγA contains three polymerase motifs
involved in DNA synthesis and a 3'→ 5'-exonuclease domain which
functions in proofreading during replication. POLγB acts as a
processivity factor, accelerating the polymerization rate and enhanc-
ing the afﬁnity of the catalytic subunit for DNA [36]. One POLγB
monomer lies close to POLγA and stimulates the holoenzyme-DNA
interaction, whereas the more distant POLγB subunit has a role in
enhancing the replication rate [33,37,38]. The distal POLγB subunit
alters the POLγA conformation and allows the enzyme to interact with
a longer stretch of template-DNA, resulting in increased processivity
of the holoenzyme. Examination of DNA binding properties by EMSA
revealed that under in vitro conditions, POLγB prefers to bind dsDNA
[39]. PolγB double-strand binding is not required for stimulation of
DNA synthesis on an ssDNA template. However, on a dsDNA template,
this PolγB binding property is essential for replisome function; it
might ensure that the polymerase stays bound to the template behind
the slower moving TWINKLE helicase and in that way helps to
coordinate TWINKLE and POLγA enzymatic activities at the mtDNA
replication fork [40].
3. Mitochondrial single-stranded DNA-binding protein (mtSSB)
Although SSB (single-stranded DNA-binding) proteins do not pos-
sess direct catalytic activity, they are key players in DNA metabolism.
SSBs prevent ssDNA from refolding and protect against nucleolytic
attacks. In contrast to other components of the mtDNA replisome
(POLγA, TWINKLE and POLRMT), human mtSSB is not homologous to
the SSB present in T7, but is instead similar to the Escherichia coli SSB
[24]. The crystal structure of human mtSSB has been solved at 2.4 Å
resolution, and the structure shows that single-stranded mtDNA
wraps around the tetrameric protein in electropositive channels
guided by ﬂexible loops [41]. Similar mtSSB proteins have been found
in Xenopus laevis [42], yeast [43], Drosophila [44] and mouse [45].
Deletion of the yeast mtSSB encoding gene (RIM1) results in total loss
of mtDNA, underscoring the importance of the protein in mtDNA
maintenance [43]. Likewise, RNAi knockdown of the DrosophilamtSSB
levels resulted in severe depletion of mtDNA in S2 cells [46]. MtSSB
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has been proposed that the protein may inﬂuence D-loop turnover
[48].
MtSSB enhances primer recognition [44] and processivity of POLγ
[49] at the mitochondrial replication fork and in that way stimulates
synthesis of mtDNA [50,51]. HumanmtSSB has a stimulatory effect on
TWINKLE unwinding activity in vitro and this activity appears to be
speciﬁc since the structurally related E. coli SSB could not stimulate
TWINKLE [52]. In vitro studies have demonstrated that POLγ and
TWINKLE can assemble on a dsDNA template with preformed rep-
lication fork and synthesize ssDNA products of ∼2 kb. Addition of
mtSSB increases the processivity of the replication machinery and
generates DNA products longer than 16 kb, which is the size of the
mammalian mtDNA molecule [20]. Together, these biochemical data
support the idea that there are direct interactions betweenmtSSB and
other members of the replication fork, but the nature of these
interactions remains to be demonstrated.
Replication stalling at regions that are difﬁcult for the replication
machinery, e.g. homopolymeric runs, has been suggested to be a
primary cause of the multiple mtDNA deletion formation in adPEO
[53]. Interestingly, in vitro studies with the X. laevis proteins showed
that mtSSB eliminates POLγ arrests within homopolymeric sequences
[54]. Therefore, mutations in mtSSB that renders the protein unable to
stimulate TWINKLE and/or POLγ may potentially lead to replication
stalling at certain sequences and hence cause mtDNA deletion.
However, to date, nomutations in themtSSB gene has been associated
with human mitochondrial disease.
4. Mitochondrial RNA polymerase (POLRMT)
Transcription of the mitochondrial genome depends on a unique
RNA polymerase that is distinct from the nuclear RNA polymerases.
POLRMT was initially identiﬁed in Saccharomyces cerevisiae and dem-
onstrated to be the product of the RPO41 gene [55,56]. The protein
was later identiﬁed in human cells and sequence analysis demon-
strated that it was structurally related to the bacteriophage T7 RNA
polymerase [25]. Unlike the T7 homologue, POLRMT cannot initiate
transcription on its own [57], but requires the assistance of two
additional transcription factors, TFAM and transcription factor B2
(TFB2M). The basal human mitochondrial transcription machinery
(for detailed review see [58]) can be reconstituted in vitro, using only
puriﬁed recombinant proteins and promoter containing DNA frag-
ments [59]. Initially, a factor related to TFB2M, TFB1M was also
described as a transcription factor, but later studies have shown that
this protein instead functions as ribosomal RNA methyltransferase
[60,61]. Disruption of the Tfb1m gene in mouse heart leads to
complete loss of adenine dimethylation of the 12 S rRNA, which in
turns cause impaired assembly of the mitochondrial ribosome, and
abolished mitochondrial translation [61].
4.1. POLRMT role in leading strand replication initiation
POLRMT is not only required for transcription, but also generates
the RNA primers used to initiate leading-strand mtDNA synthesis at
the origin of heavy strand DNA replication (OH) (Fig. 3) [21,62,63].
Leading strand DNA synthesis is primed by a ∼100 nt RNA primer
formed by transcription initiation from the light strand promotor
(LSP) [63]. LSP transcription also generates genome length transcripts,
which subsequently are processed to generate the transcript encoding
ND6 and several tRNA molecules. In mammals, the majority of H-
strand DNA replication initiation events is terminated about ∼600 bp
downstream of OH. The arrested strand remains stably hybridized to
the parental molecule, thus forming a triple-stranded structure with a
displaced parental H-strand. This triplex structure is known as the
displacement loop (D-loop) [64,65]. The molecular function of the D-
loop structure remains largely unknown, but it is critical for replicationof mtDNA [66] and may also have a role in nucleoid segregation [67].
POLγ holoenzyme is required for D-loop formation and modulation of
POLγB expression in cultured human cells results in a decrease of the
D-loop DNA and altered nucleoid structure [68].
Early in vivo studies demonstrated the existence of a precursor
RNA primer required for initiation of mtDNA synthesis at OH. The
primer was initiated at LSP and remained associated with mtDNA,
forming a stable RNA-DNA hybrid [69]. The molecular basis for this
peculiar behavior is still unresolved. At most sequence, the double-
stranded DNA template is reannealed after passage of a RNA po-
lymerase and the newly transcribed RNA molecule thus only remains
annealed to a short stretch of unwound DNA template within the
transcription bubble formed by the moving RNA polymerase [70]. The
formation of a stable RNA-DNA hybrid near LSP therefore suggests
that there may exist speciﬁc proteins or DNA/RNA sequence elements
that prevent reannealing of the DNA template. It appears likely that
understanding the underlying mechanism behind this phenomenon
will prove important, not only for our understanding of primer
formation, but also for our understanding of the mitochondrial D-loop
function.
In order to deﬁne the exact initiation site for DNA synthesis, i.e. the
transition from primer to active DNA synthesis, replicating mtDNA
molecules have been isolated from cells and RNase H cleavage has
been used tomap the exact RNA to DNA transitions sites within the D-
loop region [71,72]. These studies have demonstrated that DNA
synthesis is initiated 5–10 nt downstream of a conserved DNA se-
quence element, denoted conserved sequence box II (CSBII) (Fig. 3). It
should be noted that most reviews locate the origin of heavy strand
DNA replication (OH) to another site, further downstream from CSBII.
In contrast to the region just downstream of CSBII, RNA to DNA
transitions has to our knowledge never been demonstrated at OH.
Instead, the classical OH has been deﬁned by isolation of DNA
replication intermediates and direct DNA sequencing [73,74]. Later
studies have also used primer extension analysis to identify the start
site of nascent DNA chains and they deﬁned all identiﬁed 5' ends as
origins [75]. Although this approach may generate relevant and
important insights it can also be risky, since it assumes that all DNA 5'
ends identiﬁed are the products of DNA synthesis initiation events,
which is not always the case. Other processes, e.g. primer processing,
which is a poorly understood aspect of mtDNA synthesis, may also
give rise to nicks in DNAmolecules. Regardless, we do believe that any
deﬁnition of a true mitochondrial origin of DNA replication requires
the direct demonstration of a RNA primer and a deﬁned region of RNA
to DNA transitions.
Early studies suggested that the primary LSP transcript must be
enzymatically processed i.e. RNase MRP, to yield the mature RNA
primer for leading strand replication [76,77]. Based on studies in vitro,
we have proposed an alternative model [59], which suggests that
primers are formed by sequence speciﬁc transcription. In fact, up to
60% of all transcription events initiated from LSP are prematurely
terminated at a region 5–10 bp downstream of CSBII, thus correlating
with the initiation sites formtDNA synthesis observed in vivo [71]. The
proposed RNAse MRP -independent mechanism relies on the
evolutionary conserved CSBII sequence and it has been shown that
mutations which destroy this sequence abolish primer formation in
vitro [72]. It should be emphasized that this model, similar to the
proposed cleavage by RNase MRP, suffers from lack of direct in vivo
evidence. It is essential that scientists within the ﬁeld develop in-
telligent assays to directly address the validity of the different models
for primer formation in vivo.
We would also like to put forward the hypothesis that the switch
between RNA to DNA is a regulated event, with implications for the
regulation of mtDNA replication levels. We build this theory on two
observations. First, primer synthesis and initiation of mitochondrial
transcription appear to be inseparable events and, therefore, it seems
unlikely that initiation of primer synthesis controls the levels of mtDNA
Fig. 3. Schematic representation of the D-loop regulatory region. The three conserved sequence blocks (CSBI, CSBII and CSBIII) are located just downstream of light-strand promoter
(LSP). Transition from RNA primer to the newly synthesized DNA has been mapped to sequence within or near CSB II [71,72]. The conserved termination-associated sequence (TAS)
elements are located at the 3' of the nascent D-loop strand and are proposed to be a major regulation point of mtDNA replication. Abbreviations: HSP, heavy-strand promoter; LSP,
light-strand promoter; OH, origin of H-strand; F, tRNA phenylalanine; P, tRNA proline.
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can effectively initiate DNA synthesis frommany different types of RNA
primers in a sequence independent manner. In stark contrast to this
observation, we have so far not been able to reconstitute transcription-
coupled replication in vitro by combining the basal replication and
transcription machinery (unpublished data). For some reason, primers
formed by transcription termination events downstreamof CSBII do not
prime initiation of mtDNA synthesis in vitro. Perhaps the primers
formed at this location adopt a structure, which cannot be directly used
by POLγ for initiation of DNA synthesis. Additional regulatory factors
may therefore be required for the process to commence.4.2. POLRMT in lagging strand DNA replication initiation
The origin of light strand replication (OL) is the preferred site for
second strand (lagging strand) initiation in vivo [71,78]. After
initiation at OH, leading-strand synthesis advances two-thirds of the
way around the genome, before it reaches a small (30-bp) non-coding
DNA region containing OL, which is then displaced in it single-
stranded form. The single-stranded OL region adopts a stem–loop
conformation and primer synthesis is initiated from the loop-region of
this structure. These primers are then used for initiation of L-strand
DNA synthesis and a region of RNA to DNA transitions has been
identiﬁed at the base of the double-stranded stem [71].
How RNA primers are formed at OL was for a long time an open
question. Reports of an OL-speciﬁc primase activity in mitochondrial
lysate were published already 25 years ago, but the corresponding
enzyme was not identiﬁed at this time [79–81]. Two recent pub-
lications, we have now identiﬁed POLRMT as the OL-speciﬁc primase
and thus established that the mitochondrial RNA polymerase primes
DNA synthesis at both the mitochondrial origins of DNA replication
[21,82].
The idea that POLRMT could function as a classical primase came
initially from a report, which puriﬁed a primase activity from nuclear
extracts of herpes simplex virus type 1-infected Vero cells [83]. The
observed activity synthesized short oligoribonucleotides and based on
biochemical characteristics the authors concluded that the responsible
enzyme most likely was POLRMT, even if the enzyme was never di-
rectly identiﬁed. In agreement with this early report, puriﬁed POLRMT
synthesizes RNA primers of 25–75 nts on a single-stranded DNA
template [21]. Furthermore, in the absence of a primase, the minimal
replisome (POLγ holoenzyme, TWINKLE andmtSSB) is unable to copy
both DNA strands from a dsDNA template [20], whereas addition of
POLRMT to the replication machinery leads to simultaneous leading
and lagging strand synthesis in vitro [21].
According to the classical model for initiation of OL activation and
initiation lagging-strand DNA synthesis, passage of the mtDNA
replicationmachinery exposes OL in its single-stranded conformation.
Strand displacement causes the origin sequence to adopt a stem–loop
structure, which is recognized by an origin-speciﬁc primase [79–81].
In agreement with this model, POLRMT has the capacity to speciﬁcallyinitiate RNA primer synthesis at the OL stem–loop structure (Fig. 4).
Primer synthesis is completed after about 25 nt. At this point, POLγ
replaces POLRMT and lagging strand DNA synthesis is initiated.
Interestingly, unlike in H-strand replication, the primer hand-off
between POLRMT and POLγ could be reconstituted in vitro [82],
suggesting that this event in OL dependent initiation is not a regulated
event. The proposed model is mainly based on in vitro data, but
receives support from two-dimensional gel electrophoresis (2D-AGE)
analysis in combination with RNAi knockdown of POLRMT. In human
cells, depletion of POLRMT generates replication intermediates with
delayed lagging strand synthesis, thereby providing evidence for
POLRMT acting as a lagging-strand primase also in vivo [82].
In summary, there is now ample evidence to support a role for
POLRMT role in mtDNA replication. POLRMT might therefore also be
considered as a possible locus for mtDNA replication-related human
diseases. The human and yeast mitochondrial RNA polymerases have,
compared to their homologue in T7, a distinctive N-terminal extension
with unknown function [25]. Deletion of this region in the yeast gene
(RPO41), while leaving the mitochondrial targeting signal, did not
affect mitochondrial transcription signiﬁcantly, but resulted in loss of
mtDNA [84]. It remains to be tested if the amino-terminal extension in
human POLRMT has an exclusive role in mtDNA replication. One can
also envisionmutations in other regions of POLRMT,which could affect
the switch between transcription and DNA synthesis, e.g. the primer
hand-off mechanism at OH between POLRMT and POLγ.5. Biochemical properties of TWINKLE
In 2001, the TWINKLE genewas identiﬁed in a search formutations
associated with deletions in mtDNA. The observation that the C-
terminal part of the TWINKLEproteinwas similar in sequence to the T7
primase/helicase (T7 gp4) required for bacteriophage DNA replica-
tion, immediately suggested that TWINKLE could be the long-sought-
after replicative helicase in mammalian mitochondria [4]. The
acronym TWINKLE stands for T7 gp4-like proteinwith intramitochon-
drial nucleoid localization. As noticed earlier, TWINKLE could together
with mtSSB and POLγ perform highly processive DNA synthesis in
vitro [20,52]. Biochemical analysis has shown that TWINKLE unwinds
dsDNA in a NTP-dependent manner in the 5' to 3' direction and that
TWINKLE requires a substrate with a 5'-loading site and a short 3'-tail
to initiate unwinding [52,85]. Expression of both human and
Drosophila TWINKLE variants that carry mutations in conserved
helicase motifs led to mtDNA depletion in cells, clearly demonstrating
that the TWINKLE helicase activity is essential in vivo [85,86].
The similarities between the N-terminal primase domain of T7 gp4
and the N-terminal domain of TWINKLE are less obvious. Human
TWINKLE lacks critical amino acids found in related primases and no
primase activity has been detected with puriﬁed TWINKLE. Bioinfor-
matic analysis suggest that this activity may have been lost relatively
recently, since conserved primase motifs can be identiﬁed in the
primary sequence of most TWINKLE orthologues, with the notable
Fig. 4. Schematic model for origin-dependent initiation of lagging-strand DNA synthesis
at OL. (A) The leading strand (H-strand) DNA replication machinery approaches the OL
sequence (yellow). (B). Upon passage, single-stranded OL is exposed and adopts a
stem–loop structure. MtSSB is unable to bind to the stem–loop and POLRMT can initiate
primers from the poly-dT stretch in the single-stranded region of OL (C). After about
25 nt (dotted red), POLRMT is replaced by POLγ, and lagging-strand DNA (L-strand)
synthesis is initiated. The newly synthesized DNA strands are shown as a red solid line.
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activity is lost in human TWINKLE, the N-terminal region is still
required for full DNA helicase activity and mtDNA replisome function
in vitro [88]. In agreementwith this conclusion, overexpression in vivo
of a TWINKLE N-terminal deletion mutant leads to stalling of the
mtDNA replication fork [85].
Even if TWINKLE binds to ssDNA, EMSA analysis has demonstrated
that dsDNA is the preferred substrate [88]. This is in contrast to the gp4
protein that preferably binds ssDNA [89]. Moreover, binding to ssDNA is
a feature required for all replicative helicases [90]. The mechanistic role
of the TWINKLE associated dsDNA binding activity is still unresolved.
Similar activities have been identiﬁed in other DNA helicases, e.g. in the
bacterial helicase DnaB, which has the capacity to translocate on dsDNA
and that has been proposed to act in resolving Holliday junctions [91].
Interestingly, TWINKLE overexpression in human cells results in a
severe decrease of Holliday junction replication intermediates
[85,92,93]. Thus, TWINKLE may have a direct role in recombination in
vivo. In fact, the TWINKLE helicase domain shows the same conserved
organization as RecA, a protein implicated in homologous recombina-
tion [94]. Nevertheless, experimental data is required to conﬁrm
TWINKLE's role in recombination. In addition, the existence of
homologous recombination events in mtDNA maintenance is still
questioned by many scientists in the ﬁeld [95–97].
Reduction of TWINKLE expression by RNAi results in mtDNA
depletion both in human and Drosophila cells and overexpression of
wild-type TWINKLE can increase mtDNA content in mouse tissue
[98,99]. Furthermore overexpression of TWINKLE in cultured cells
increased mtDNA levels modestly [85]. However, even if TWINKLE
may inﬂuence mtDNA copy number if overexpressed, it still remains
to be demonstrated that it actually functions as an important reg-
ulator of copy number under normal, physiological conditions.
Similar to related helicases, TWINKLE has the capacity to form
multimers [4,88,100,101] and EM-microscopy has revealed that
puriﬁed TWINKLE may form both hexa- and heptamers (Bäckström
et al., manuscript in preparation). Multimerization is dependent on a
short linker region, which connects the N- and C-terminal domains of
TWINKLE. Mutations that affects this linker region affects multi-
merization and DNA helicase activity [102]. In a related way, the T7
gp4 linker region is required for oligomerization, ssDNA binding and
thus for helicase activity of the enzyme [90,103].
There have been reports of a shorter, TWINKLE splice variant
termed TWINKY, which lacks exon ﬁve and has a unique C-terminal
tail [4]. It is questionable if this form of TWINKLE is of physiological
relevance, since in contrast to TWINKLE, TWINKY does not form
multimers or does not localize to the nucleoids [85,88]. Moreover, the
TWINKY splice variant is not conserved in the mouse [98] or in
Drosophila melanogaster [99]. Nevertheless, about 20% of the mRNAs
transcribed from the human PEO1 gene codes for the TWINKY isoform
[104]. Perhaps splicing regulates the levels of active TWINKLE and
TWINKY may thus represent an inactive form of the protein.
6. TWINKLE mutations in disease
To date, 31 different TWINKLE mutations have been reported to
cause accumulation of deletions or depletion of the mtDNA, resulting
in mitochondrial energy defects which give rise to neuro-muscular
symptoms (Fig. 5). All the dominant mutations cause autosomal
dominant progressive external opthalmaplegia (adPEO), a late-onset
mitochondrial disease, which generally manifests as exercise intoler-
ance and muscle weakness, most severely in the ocular muscles
[4,105]. Some patients have additional symptoms such as cardiomy-
opathy, mild ataxia, parkinsonism and major depression [106].
Patients with adPEO gradually accumulate mtDNA deletions in post-
mitotic tissues but do not usually present mtDNA depletion [107,108].
In most patients the adPEO-causing TWINKLE mutations are hetero-
zygous mutations in conserved amino acids [109].
Fig. 5. Schematic representation of TWINKLE and mutations in the protein that cause
disease [4,104,109,115,116,185–194]. The gray line indicates the 13aa duplication
(aa352–364) found in a Finnish adPEO family.
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A large number of disease causing mutations have been identiﬁed
in and around the linker-region, and based on studies with the T7 gp4
homologue, they are predicted to interferewith themultimerization of
the protein [103,110] Accordingly, some of the linker-region mutants
(R374Q and I367T) derived from baculovirus expression of recombi-
nant TWINKLE are strictly found as monomers and are therefore in
pure form inactive in all in vitro assays [102]. However, upon
expression in human (R374Q) or Schneider cells (R374Q and I367T),
these proteins are still able to form multimers, due to the presence of
endogenous wild-type TWINKLE [99,101]. The dominant negative
effect of the R374Q and I367T adPEO mutants is due to the hexameric
nature of the active enzyme. The presence of even one mutated
monomer can disturb the assembly and function of the TWINKLE
holoenzyme. The amino acid 352–364 duplication appears to have
moderate problems with multimerization, although some high
molecular weight multimers could still be detected upon expression
in human cells [101].
Other linker-region mutants did not show a strong effect on
TWINKLE multimerization in vitro. These mutations might therefore
have other consequences on protein activity. Alternatively, the
multimerization defects in these mutants are subtler and may not
show in the gel-ﬁltration experiments, but still interfere with in vivo
helicase processivity. In support of this, all investigated linker-region
mutants have a decreased helicase and ATPase activity, even though
some are able to form multimers [101,102]. In this group of mutant
proteins, S369P and L381P have been suggested to interfere with the
ATP-binding capacity of the helicase. Overexpression of TWINKLE
mutants R374Q, S369P and A359T in human cells leads to mtDNA
depletion and severe replication stalling, clearly demonstrating their
dominant effect. The A359T TWINKLE variant appears to exhibit a
relatively mild defect. In agreement with this observation, this is the
only alteration that has been identiﬁed in patients who are
homozygous for adPEO causing mutations [4]. Likewise, the pheno-
type of the transgenic A360T (corresponding to the A359T patient
mutation) mice was very mild [111]. These data thus support the
hypothesis that many of the more severe TWINKLE adPEO mutants
would be embryonically lethal if present in a homozygous state.
6.2. AdPEO mutations in the C-terminal of TWINKLE
Several adPEO mutations are located in the C-terminal helicase
domain between Walker motifs A and B (Fig. 5). Three of these
disease-associated TWINKLE mutants have been characterized in
relatively recent studies [99,101,102]. Although there is no experi-mentally determined three-dimensional structure of TWINKLE, a
molecular model of TWINKLE has been constructed by homology
modeling of the T7 gp4 [102,112]. In this model, residues A475 and
F485 in the helicase domain are in close contact with R374 and F370 in
the linker region, suggesting that these residues are required to form
stable mulitmers. This conclusion is supported by the observation that
the A475P adPEO TWINKLE variant wasmigratingmainly asmonomer
on a gel-ﬁltration column [102]. The loss of helicase activity due to
lack of proper hexamer formation was also demonstrated by
overexpression of Drosophila TWINKLE with the corresponding
amino acid change (A442P), which caused a lethal phenotype in S2
cells due to a severe mtDNA depletion [99]. Furthermore, a phe-
nylalanine to leucine change in residue 485 also results in defective
multimerization, although to a lesser extent. Another amino acid
change in TWINKLE (W474C) is not predicted to directly interact with
the linker region and this mutant is able to hexamerize; in spite of
this, the in vitro helicase activity was reduced with 70% [4,101,102]. In
support of the reduced activity, expression of W474C in human cells
leads to a decrease in mtDNA level. 2D-AGE analysis of these cells
showed a distinct pattern of replication intermediates. In contrast to
other TWINKLE-adPEO mutants, intermediates appeared that are
indicative of reduced initiation of leading strand replication while
elongation on other parts of the mtDNA was less affected [101]. This
ﬁnding suggests that the W474C mutation has a speciﬁc effect on
initiation. Furthermore, immunocytochemistry and confocal micros-
copy showed that nucleoid morphology was disturbed in the W474C
expressing cells, hinting at an mtDNA segregation defect.
6.3. AdPEO mutations in the N-terminal of TWINKLE
In general, the N-terminally located TWINKLE adPEOmutations do
not primarily seem to affect multimerization (apart from K319E).
Nevertheless, all mutants studied have a decreased helicase activity
[101,113]. This could mostly be explained by a reduction in ssDNA
binding activity and ATPase hydrolysis (W315L, K319E, P335L). Al-
though signiﬁcantly slower than the wild-type TWINKLE, R334Q and
K319T can still hydrolyze ATP in the presence of ssDNA. The K319T
change inﬂuenced unwinding rate only modestly, but was anyway
unable to stimulate POLγ in an in vitro replication assay. In contrast,
R334Q had the ability to support in vitro replication even though its
helicase activity was strongly reduced [113].
6.4. A TWINKLE mouse model for adPEO disease
A mouse model has been made for PEO disease by expressing a
mouse TWINKLE mutant that corresponds to a patient mutation
(duplication aa 353–364) [111]. The mice accumulate multiple
mtDNA deletions, but unlike PEO patients the physical performance
was not compromised. The ﬁrst histological signs of mitochondrial
myopathy were identiﬁed at the age of 1 year. Taking into account the
expected lifespan of mice, this mimics the relative age of onset in
human disease. The mild effect of this mutation might be useful for
evaluation of therapeutic strategies for mitochondrial myopathy.
Recently it was demonstrated that a ketogenic diet slows down
mitochondrial myopathy progression in these mice [114]. Analysis of
various tissues from the “deletor” mice showed enhanced replication
stalling already in 6 weeks oldmice [101]. The 3'-deletion breakpoints
in the mouse were found to overlap with the human base pair 16070,
which has been identiﬁed as a frequent breakpoint in PEO patients,
suggesting deletions accumulate by a similar mechanism [53,111].
6.5. Recessive TWINKLE mutations
More recently, autosomal recessive TWINKLE mutations have been
identiﬁed that cause tissue-speciﬁcmtDNAdepletion [104,115,116]. The
homozygous Y508C alteration results in infantile onset spinocerebellar
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deletionswere not found, but brain- and liver-speciﬁcmtDNAdepletion
led to OXPHOS defects in these tissues [118]. Based on the molecular
model of TWINKLE it appears that residueY508 formsapocketwith I367
in the linker-region, suggesting that this mutant might have difﬁculty
with hexamerization [102]. Surprisingly, the Y508C change did not
compromise the in vitro performance of TWINKLE, including hexamer-
ization [118]. This report further showed that TWINKLE-Y508C had a
signiﬁcantly increased helicase activity. Hypothetically, this could
disturb the coordination between the helicase and the POLγ holoen-
zyme. The TWINKLE IOSCA alteration was also found in patients
compound heterozygous for the A318T and Y508C mutation, but
manifesting in a more severe disease with an earlier age onset. In the
presence of onewild-type copy, the alanine to threonine change did not
result in disease, suggesting this mutation is recessive [115]. Two
patients homozygous for T457I presented a hepatocerebral form of
mtDNA depletion [116]. Severely decreased in vitro helicase activity
(50%) might explain why this mutation leads to mtDNA depletion, but
why a recessive mutation only affects certain tissues (brain, liver)
remains to beelucidated. POLγAmutations can also cause tissue-speciﬁc
mtDNA depletion leading to Alpers syndrome [119] or ataxia-neurop-
athy [120,121] (for a detailed review see [122]).
7. Replication fork defects and disease mechanisms
More then two decades ago, mtDNA deletions were identiﬁed in
patients with mitochondrial myopathies [123]. As discussed above,
mutations in POLγA, POLγB and TWINKLE can lead to the accumu-
lation of multiple mtDNA deletions in post-mitotic tissue and causing
progressive respiratory chain deﬁciency [4,30,124]. The precise
mechanism by which these nuclear gene defects result in the
accumulation of deletion in the mitochondrial genome is now starting
to unravel. It appears that the autosomal dominant mutations cripple
the mitochondrial replication fork, causing frequent stalling/pausing
of the replication machinery [85,101]. This stalling may be the ﬁrst
step in deletion formation [101,111]. Stalling will also be affected by
availability of DNA precursors–dNTP–and asymmetric dNTP pools
might help explain tissue-speciﬁc replication stalling and maybe also
the tissue-speciﬁc consequences of the accumulation of stalled forks
[125]. The major supply of dNTPs in mitochondria is by de novo
synthesis, which is strongly down-regulated in postmitotic cells [126].
Furthermore, it is known that alteration in nucleotide pools can cause
increased mutagenesis [127–129]. Particularly, already defective
replication fork could under such conditions frequently halt replica-
tion, especially around homonucleotide repeats when the local
concentration of a certain dNTP can be dangerously low. The idea is
supported by deletion mapping analysis, which demonstrated that
homopolymeric runs often surround the breakpoints in post-mitotic
tissue from adPEO patients [53]. Also in model organisms, like yeast
and bacteria, it has been demonstrated that defects in replication fork
proteins lead to stalling, especially at sequence repeats [130–133].
A common transitional state in order to restore the replication fork
after such a stalling event is double-strand break (DSB) formation
[134]. Induction of DSBs in mice by targeting a restriction enzyme to
mitochondria resulted in the accumulation of multiple deletions,
strengthening the idea that DSB could predispose mtDNA deletions
[135]. A relatively high occurrence of DSBs might enhance the repair
pathways [136], a state that is reported to produce genome instability
[134,137]. DSB repair pathways in mitochondria have not been
studied extensively, but double-strand break rejoining activities have
been reported in mitochondrial extracts [138,139].
Nucleotide pool involvement in mtDNA maintenance could also
explain the ANT1 and RRM2B gene mutations found in adPEO patients,
since both genes are directly implicated in nucleotide metabolism
[140,141]. ThemechanismbywhichOPA1, another adPEO disease gene,
causes mtDNA deletions is more speculative [142]. OPA1 plays a part ininner-membrane fusion, thus the adPEO mutations in this gene could
lead to a defect in nucleoid segregation [143]. Most OPA1 mutations
associated with mtDNA deletions are found in the catalytic GTPase
domain of the protein [144,145] and impaired GTP hydrolysis could
perhaps give rise to deoxyribonucleotide asymmetry.
8. MtDNA replication mechanism
The exact mechanism of mitochondrial DNA replication in animals
has been a matter of controversy in recent years (Fig. 6) [146–148].
For several decades, mtDNA replication has been considered to occur
through a strand-displacement mode (SDM), where leading- and
lagging-strands are synthesized asymmetrically and unidirectionally
from well-deﬁned origins, OH (the leading strand origin) and OL (the
lagging-strand origin) [149–151]. SDM replication of mtDNA shares
some similarities with ColE1 plasmid replication [152].
8.1. Strand displacement mtDNA replication
As discussed earlier in more detail, leading-strand replication is
initiated from a POLRMT-synthesized primer (Fig. 3) [63]. The mi-
tochondrial replisome fork can start synthesis by extension of this
primer and then continues moving unidirectionally (Fig. 6A). The
replication fork often arrests at a 15-bp conserved sequence called the
termination-associated sequence (TAS); in that way a more or less
stable D-loop-containing molecule is generated [64,65]. The D-loop is
a triple stranded region that spans about 650 bp in human [151]. This
premature arrest could be one possible regulation point of mtDNA
synthesis. Others have suggested that the D-loop functions in
recruiting proteins for the formation and or segregation of mtDNA
nucleoids [67,153]. When the leading strand synthesis proceeds
beyond the TAS sequence the replication fork continues unidirection-
ally leaving behind extensive regions of ssDNA (Fig. 6A). Binding of
mtSSB protects the single-stranded DNA, and unspeciﬁc priming of
the lagging strand by POLRMT is blocked or strongly reduced [82].
Two thirds of the way around the genome TWINKLE unwinds the
lagging strand replication initiation site (OL) (Figs. 6A and 4). Upon
passage of the replication fork, OL becomes single stranded and forms
a stem–loop structure [78,154]. The partial double-stranded structure
of the OL (stem structure) prevents mtSSB binding and in that way
promotes speciﬁc initiation from the lagging strand origin. POLRMT
initiates primer synthesis from a poly dT repeat in the single-stranded
loop region of OL [82]. Once POLγ replaces POLRMT, the lagging strand
DNA synthesis is initiated (Figs. 6A and 4). In this model both strands
can be synthesized continuously.
Alternative lagging strand initiation sites, in addition to OL, are
predicted by in silico methods [155–157], and shown using atomic-
force microscope (AFM) [158]. Our recent ﬁnding that POLRMT can
prime lagging strand replication gives the possibility to biochemically
test other regions of the mitochondrial genome on alternative lagging
strand initiation [82].
8.2. Strand-coupled and RITOLS mtDNA replication
Studies by Holt and coworkers have suggested the existence of two
additional replication modes. (Fig. 6B) [159,160]. Data obtained by
2D-AGE revealed that a signiﬁcant portion of the mtDNA formed
duplex replication intermediates derived from coupled leading and
lagging stand DNA synthesis [159]. The strand-coupled mechanism
was suggested to initiate bidirectionally from a broad zone, OriZ [161].
The strand coupled intermediates were shown to be fully double
stranded [148,162]. In the initial report other replication intermedi-
ates were also clearly visible, and they were thought to present the
SDMmode of mtDNA replication [159]. However further studies using
2D-AGE analysis demonstrated that these replication intermediates
were RNaseH-sensitive [163]. This observation led to a proposal that
Fig. 6. Replication modes of mammalian mtDNA. (A) Strand-displacement replication mode. Replication of leading strand (H-strand) initiates at OH and proceeds unidirectionally
(black arrow), displaying the parental H-strand as ssDNA. When OL (or OLalt) is exposed, the lagging strand (L-strand) synthesis initiates in the opposite direction (gray arrow). This
ﬁgurewas adapted from [158]. (B) RITOLS (left pathway) and strand coupled (right pathway)mode ofmtDNA replication. In the RITOLSmode, replication of leading strand (H-strand)
initiates at a discrete origin (OR) and proceeds unidirectionally (black arrow), displaying the parental H-strand. The lagging strand (L-strand) is initially laid down as RNA (red line)
using the displayed H-strand as template. The RNA is subsequently replaced by DNA (gray arrow), which probably starts as soon as OL is exposed by a yet unclear mechanism. In the
strand-coupled mode (right pathway) initiation of both leading- (H-strand) and lagging strand (L-strand) synthesis occurs bidirectionally frommultiple origins across a broad zone
downstream of OH. This is followed by progression of both forks until the forks arrest at OH.
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rich DNA synthesis that was initiated unidirectionally from the non-
coding region [160,162]. According to this replication mode, the
lagging strand is initially laid down as RNA before being converted to
DNA; therefore it is referred to as ribonucleotide incorporation
throughout the lagging strand (RITOLS). Both SDM and RITOLS
replication predict delayed second-strand synthesis, but in the RITOLS
model mtSSB is replaced by RNA (Fig. 6B) [160]. Furthermore, this
RNA might be processed to form many short RNA primers that could
be used to initiate lagging strand DNA synthesis discontinuously
[160]. The existence of Okazaki-like fragments has not been
demonstrated, but mitochondria do contain an enzymatic machinery
suitable for Okazaki fragment maturation [164–167].
In support of the existent of the RITOLS mode, extensive and stable
partial hybridized RNA was observed throughout the mtDNA of mice
[168] conﬁrming that the RNA-rich replication intermediates seen on
2D-AGE are not simply RNAmolecules that attach to the DNA after lysis
ofmitochondria [160].However, in the samestudy theseRNA transcripts
could not be shown to be used as primer for DNA replication [168].
The fact thatmouse andhumanmtDNAcontain ribonucleotidesat all
stages of maturity was already demonstrated in a much over looked
article in 1973 [169]. Whether or not representing replication
intermediates it can be concluded that from all points of view the
presence of large amounts of RNAhybridized tomtDNA is intriguing and
calls for additional experiments. Theextent of ribonucleotides inmtDNA
is alsoa critical questionwith relevance to our interpretationofmethods
that are used to quantify mtDNA such asmtDNAheteroplasmy analysis.
8.3. Replication mode discussion
In conclusion, the mode of mtDNA replication in mammalian cells
is still a debated issue [164,170]. However, the recent reconstitution of
OL dependent lagging strand initiation in vitro shares importantcharacteristics with the proposed SDM mode of replication [82]. In
addition, SDM replication is based on a large amount of impressive
experimental data using EM, AFM, strand isolation, 5'-end character-
ization as well as pulse- and pulse-chase labeling (see [171] and
references within). Likewise, the careful preparations of the DNA
samples used in the 2D-AGE method [172] seem unlikely to produce
reoccurring experimental artifacts. Moreover, the 2D-AGE technique
[173,174] is a widely accepted method used to examine mechanisms
of phage, plasmid, bacterial, yeast and human nuclear DNA replication
[175–181]. Therefore it is not unlikely that different tissue- and/or
metabolic DNA replication modes take place in mitochondria as has
been demonstrated in other replication systems [182,183]. For
example, bacteriophage T4, whose DNA replication has been analyzed
in signiﬁcant detail, uses two distinct modes of replication [182]. Early
in infection the DNA synthesis is origin-dependent, but as the
infection progresses, the recombination-dependent mechanism of
replication initiation becomes predominant [184].Acknowledgments
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